The FDA rejected linvoseltamab, Regeneron’s experimental antibody for multiple myeloma, the company announced Wednesday morning.
In an earnings call earlier this …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The gut-inhabiting bacteria in pre-type 2 diabetes (pre-T2D) patients.
Cambridge, UK-based startup CellCentric is receiving $25 million to finish ongoing clinical studies and get some extra runway in the form of a cash infusion
The FDA warned the public Thursday that certain probiotic products given to preterm infants in hospital settings are potentially dangerous. The agency also sent warning